Last edition
News about "bacterial infections"
Qnovia Secures Global License for Novel Antimicrobial Peptide to Combat Drug-Resistant Infections
Qnovia has obtained worldwide exclusive rights from the University of Virginia to develop and commercialise the D8 antimicrobial peptide, a novel therapy designed to target multidrug-resistant bacterial infections through a unique mechanism.
Bacterial Infections | 31/07/2026 | By News Bureau
Global Topical Antibiotics Market Projected to Surpass USD 11 Billion by 2032
The global topical antibiotics market, valued at USD 6.42 billion in 2024, is expected to reach nearly USD 11.20 billion by 2032.
Bacterial Infections | 14/07/2025 | By Dineshwori | 299
Acurx Pharmaceuticals Secures Japanese Patent for DNA Polymerase IIIC Inhibitors
Acurx Pharmaceuticals has secured a new patent from the Japanese Patent Office for its DNA Polymerase IIIC Inhibitors, expanding its global intellectual property portfolio in antimicrobial drug development.
Bacterial Infections | 20/02/2025 | By Abha | 314
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy